文献速递临床试验与 GCP流行病学与生物统计

邮寄人乳头瘤病毒自采样套件提高宫颈癌筛查的策略:一项随机临床试验

Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2023-01-01

在Kaiser Permanente Washington系统内开展的随机临床试验纳入31355名30-64岁女性,按筛查史分层比较直接邮寄与主动申请HPV自采样套件对6个月内筛查完成率的影响。对于到期应筛查者,直接邮寄组筛查完成率较教育组提高14.1%(95%CI 11.2%-16.9%),主动申请组提高3.5%(95%CI 1.2%-5.7%);对于逾期未筛查者,直接邮寄组提高16.9%(95%CI 13.8%-20.0%);对于筛查史不明者,主动申请组提高2.2%(95%CI 0.5%-3.9%)。

要点

  • 对到期或逾期未筛查者,直接邮寄HPV自采样套件可提高筛查完成率。
  • 对筛查史不明者,主动申请方式仅轻微提高筛查完成率。
  • 实施HPV自采样应优先对到期或逾期者采用直接邮寄外展。

核心结论

  • 在美国一个医疗系统内,直接邮寄自采样套件使到期或逾期筛查者的宫颈癌筛查完成率提高超过14%。
  • 主动申请方式对筛查完成率的提高幅度很小。
  • 为增加筛查依从性,实施HPV自采样的系统应优先对到期或逾期筛查者采用直接邮寄外展。
  • 对筛查史不明者,有必要测试替代外展方法并额外努力记录筛查史。

研究设计与样本

  • 随机临床试验,在美国Kaiser Permanente Washington综合医疗系统开展。
  • 通过电子健康记录识别30至64岁、女性性别、有初级保健临床医生且未行子宫切除术的个体,于2020年11月20日至2022年1月28日入组,随访至2022年7月29日。
  • 意向性治疗分析纳入31355名随机个体,平均(SD)年龄45.9(10.4)岁。
  • 到期应筛查者随机接受常规护理(n=3671)、教育(n=3960)、直接邮寄(n=1482)或主动申请(n=3956)。
  • 逾期未筛查者随机接受常规护理(n=5488)、教育(n=1408)或直接邮寄(n=1415);筛查史不明者随机接受常规护理(n=2983)、教育(n=3486)或主动申请(n=3506)。

主要发现

  • 到期应筛查者中,直接邮寄组筛查完成率61.7%(914例)较教育组47.6%(1885例)提高14.1%(95%CI 11.2%-16.9%),主动申请组51.1%(2020例)较教育组提高3.5%(95%CI 1.2%-5.7%)。
  • 逾期未筛查者中,直接邮寄组筛查完成率35.7%(505例)较教育组18.8%(264例)提高16.9%(95%CI 13.8%-20.0%)。
  • 筛查史不明者中,主动申请组筛查完成率18.1%(634例)较教育组15.9%(555例)提高2.2%(95%CI 0.5%-3.9%)。

临床怎么用

  • 作者建议,实施HPV自采样的系统应优先对到期或逾期筛查者采用直接邮寄外展以增加筛查依从性。
  • 作者认为,对筛查史不明者,有必要测试替代外展方法并额外努力记录筛查史。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Optimal strategies for increasing cervical cancer screening may differ by patient screening history and health care setting. Mailing human papillomavirus (HPV) self-sampling kits to individuals who are overdue for screening increases adherence; however, offering self-sampling kits to screening-adherent individuals has not been evaluated in the US. OBJECTIVE: To evaluate the effectiveness of direct-mail and opt-in approaches for offering HPV self-sampling kits to individuals by cervical cancer screening history (screening-adherent and currently due, overdue, or unknown). DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted in Kaiser Permanente Washington, a US integrated health care delivery system. Individuals aged 30 to 64 years with female sex, a primary care clinician, and no hysterectomy were identified through electronic health records (EHRs) and enrolled between November 20, 2020, and January 28, 2022, with follow-up through July 29, 2022. INTERVENTIONS: Individuals stratified as due (eg, at the time of randomization, these individuals have been previously screened and are due for their next screening in ≤3 months) were randomized to receive usual care (patient reminders and clinician EHR alerts [n = 3671]), education (usual care plus educational materials about screening [n = 3960]), direct mail (usual care plus educational materials and a mailed self-sampling kit [n = 1482]), or to opt in (usual care plus educational materials and the option to request a kit [n = 3956]). Individuals who were overdue for screening were randomized to receive usual care (n = 5488), education (n = 1408), or direct mail (n = 1415). Individuals with unknown history for screening were randomized to receive usual care (n = 2983), education (n = 3486), or to opt in (n = 3506). MAIN OUTCOMES AND MEASURES: The primary outcome was screening completion within 6 months. Primary analyses compared direct-mail or opt-in participants with individuals randomized to the education group. RESULTS: The intention-to-treat analyses included 31 355 randomized individuals (mean [SD] age, 45.9 [10.4] years). Among those who were due for screening, compared with receiving education alone (1885 [47.6%]), screening completion was 14.1% (95% CI, 11.2%-16.9%) higher in the direct-mail group (914 [61.7%]) and 3.5% (95% CI, 1.2%-5.7%) higher in the opt-in group (2020 [51.1%]). Among individuals who were overdue, screening completion was 16.9% (95% CI, 13.8%-20.0%) higher in the direct-mail group (505 [35.7%]) compared with education alone (264 [18.8%]). Among those with unknown history, screening was 2.2% (95% CI, 0.5%-3.9%) higher in the opt-in group (634 [18.1%]) compared with education alone (555 [15.9%]). CONCLUSIONS AND RELEVANCE: Within a US health care system, direct-mail self-sampling increased cervical cancer screening by more than 14% in individuals who were due or overdue for cervical cancer screening. The opt-in approach minimally increased screening. To increase screening adherence, systems implementing HPV self-sampling should prioritize direct-mail outreach for individuals who are due or overdue for screening. For individuals with unknown screening history, testing alternative outreach approaches and additional efforts to document screening history are warranted. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04679675.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Winer RL, Lin J, Anderson ML, et al. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial. JAMA. 2023. PMID: 38015219. doi:10.1001/jama.2023.21471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。